Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Controlled delivery of EYE-001 encapsulated in PLGA microspheres

Feb. 7, 2003

SBIR grant supports MitoKor efforts in glaucoma

Feb. 5, 2003

NDA filing planned for PDT therapy for AMD

Feb. 4, 2003

T-588 prevents retinal ganglion cell death in rats with elevated IOP

Jan. 29, 2003

FDA advisory committee to review Vitrase NDA

Jan. 29, 2003

Alcon claims three series of 5-HT2 agonists with utility in glaucoma therapy

Jan. 23, 2003

Novartis obtains rights to pirenzepine for myopia from Valley Forge

Jan. 20, 2003

InSite Vision finalizes ISV-401 phase III trial protocol

Jan. 20, 2003

Inspire prepares to submit NDA for diquafosol by mid-2003

Jan. 14, 2003

Restasis receives FDA approval

Jan. 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...